Targeted drug therapy in non-small cell lung cancer: Clinical significance and possible solutions-Part I

Non-small cell lung cancer (NSCLC) comprises of 84% of all lung cancer cases. The treatment options for NSCLC at advanced stages are chemotherapy and radiotherapy. Chemotherapy involves conventional nonspecific chemotherapeutics, and targeted-protein/receptor-specific small molecule inhibitors. Biol...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Expert opinion on drug delivery Jg. 18; H. 1; S. 73 - 102
Hauptverfasser:	Upadhya, Archana, Yadav, Khushwant S., Misra, Ambikanandan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England Taylor & Francis 02.01.2021
Schlagworte:	immunotherapy Non-small cell lung cancer resistance targeted therapy therapeutics in clinics targeted therapy therapeutics in clinics resistance Non-small cell lung cancer immunotherapy
ISSN:	1742-5247, 1744-7593, 1744-7593
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!